U.S. flag

An official website of the United States government

NM_000368.5(TSC1):c.2039G>A (p.Gly680Glu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jan 3, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002256018.4

Allele description [Variation Report for NM_000368.5(TSC1):c.2039G>A (p.Gly680Glu)]

NM_000368.5(TSC1):c.2039G>A (p.Gly680Glu)

Gene:
TSC1:TSC complex subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.13
Genomic location:
Preferred name:
NM_000368.5(TSC1):c.2039G>A (p.Gly680Glu)
HGVS:
  • NC_000009.12:g.132904413C>T
  • NG_012386.1:g.45221G>A
  • NM_000368.5:c.2039G>AMANE SELECT
  • NM_001162426.2:c.2036G>A
  • NM_001162427.2:c.1886G>A
  • NM_001362177.2:c.1676G>A
  • NP_000359.1:p.Gly680Glu
  • NP_000359.1:p.Gly680Glu
  • NP_001155898.1:p.Gly679Glu
  • NP_001155899.1:p.Gly629Glu
  • NP_001349106.1:p.Gly559Glu
  • LRG_486t1:c.2039G>A
  • LRG_486:g.45221G>A
  • LRG_486p1:p.Gly680Glu
  • NC_000009.11:g.135779800C>T
  • NM_000368.3:c.2039G>A
  • NM_000368.4:c.2039G>A
  • p.(Gly680Glu)
Protein change:
G559E
Links:
Tuberous sclerosis database (TSC1): TSC1_00128; dbSNP: rs118203623
NCBI 1000 Genomes Browser:
rs118203623
Molecular consequence:
  • NM_000368.5:c.2039G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001162426.2:c.2036G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001162427.2:c.1886G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001362177.2:c.1676G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Hereditary neoplastic syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002530953Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(May 21, 2021)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV002723029Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jan 3, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE.

Dabora SL, Sigalas I, Hall F, Eng C, Vijg J, Kwiatkowski DJ.

Ann Hum Genet. 1998 Nov;62(Pt 6):491-504.

PubMed [citation]
PMID:
10363127

A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients.

Young JM, Burley MW, Jeremiah SJ, Jeganathan D, Ekong R, Osborne JP, Povey S.

Ann Hum Genet. 1998 May;62(Pt 3):203-13.

PubMed [citation]
PMID:
9803264

Details of each submission

From Sema4, Sema4, SCV002530953.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002723029.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The p.G680E variant (also known as c.2039G>A), located in coding exon 14 of the TSC1 gene, results from a G to A substitution at nucleotide position 2039. The glycine at codon 680 is replaced by glutamic acid, an amino acid with similar properties. This alteration, designated as DNA change G2260A (protein change: G680E), was detected with an allele frequency of 0.6% in a cohort of 79 patients satisfying established diagnostic criteria for tuberous sclerosis. The alteration is described as a non-pathogenic polymorphism by study authors (Young JM et al. Ann. Hum. Genet., 1998 May;62:203-13). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025